Device Cos. Get FDA Guidance On Computer Simulation

Law360, New York (January 17, 2014, 4:35 PM EST) -- The U.S. Food and Drug Administration on Friday explained what sort of information is required of device makers when submitting data from computerized simulations as part of approval applications, a move aimed at eliminating confusion about agency expectations and harmonizing reviews.

Much of the draft guidance took a high-level approach to formatting of sections on so-called computational modeling and simulation, or CM&S, that are included in applications for product approval.

The FDA, for example, provided a template describing how various sections of submissions should be labeled...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.